ONCOCYTE CORP (OCX)
Institutional ownership reported to the SEC as of Q1 2025, across 26 quarters.
1
Reporting holders
$126.9K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Defender Capital, LLC. | $126.9K | 44,378 | 0.05% | 17q | -5.7%-$7.7K |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2025 | 1 | $126.9K | 44,378 | 0 | 0 | 1 | 0.0% |
| Q4 2024 | 1 | $112.0K | 47,078 | 0 | 0 | 1 | 0.0% |
| Q3 2024 | 1 | $169.2K | 59,353 | 0 | 1 | 0 | 0.0% |
| Q2 2024 | 2 | $3.4M | 1,152,395 | 0 | 1 | 1 | 0.0% |
| Q1 2024 | 2 | $2.4M | 810,171 | 0 | 0 | 1 | 0.0% |
| Q4 2023 | 2 | $2.0M | 825,936 | 0 | 1 | 1 | 0.0% |
| Q3 2023 | 2 | $2.7M | 833,802 | 0 | 0 | 2 | 0.0% |
| Q2 2023 | 42 | $21.1M | 91,566,588 | 5 | 11 | 8 | 0.0% |
| Q1 2023 | 47 | $19.5M | 55,057,331 | 1 | 4 | 17 | 0.0% |
| Q4 2022 | 50 | $19.0M | 59,099,392 | 11 | 8 | 13 | 0.0% |
| Q3 2022 | 60 | $48.4M | 66,154,691 | 5 | 9 | 22 | 0.0% |
| Q2 2022 | 68 | $62.0M | 68,728,019 | 12 | 15 | 23 | 0.2% |
| Q1 2022 | 83 | $81.4M | 54,350,800 | 9 | 18 | 31 | 0.3% |
| Q4 2021 | 84 | $121.2M | 55,523,005 | 7 | 28 | 27 | 0.8% |
| Q3 2021 | 95 | $203.2M | 56,558,585 | 16 | 36 | 29 | 0.7% |
| Q2 2021 | 91 | $326.4M | 56,557,245 | 13 | 26 | 33 | 0.5% |
| Q1 2021 | 87 | $285.1M | 54,526,052 | 32 | 33 | 11 | 0.7% |
| Q4 2020 | 60 | $79.1M | 32,857,474 | 15 | 25 | 9 | 0.7% |
| Q3 2020 | 56 | $43.5M | 31,303,667 | 8 | 26 | 12 | 0.0% |
| Q2 2020 | 63 | $63.5M | 33,112,354 | 15 | 29 | 10 | 0.0% |
| Q1 2020 | 55 | $67.8M | 27,675,326 | 9 | 18 | 15 | 0.0% |
| Q4 2019 | 52 | $58.9M | 26,198,061 | 7 | 15 | 16 | 0.0% |
| Q3 2019 | 54 | $39.9M | 18,983,072 | 13 | 15 | 16 | 0.0% |
| Q2 2019 | 49 | $40.0M | 16,062,583 | 18 | 13 | 12 | 0.0% |
| Q1 2019 | 47 | $63.7M | 16,120,406 | 33 | 9 | 0 | 0.0% |
| Q4 2018 | 15 | $11.5M | 8,332,745 | 0 | 1 | 0 | 0.0% |